Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2009-01-21

FDA Approved: PERPHENAZINE AND AMITRIPTYLINE HYDROCHLORIDE — Supplemental Application (Mylan Pharmaceuticals Inc.)

View source ↗

Summary

FDA approved a supplemental application for the generic combination product PERPHENAZINE AND AMITRIPTYLINE HYDROCHLORIDE from Mylan Pharmaceuticals.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • PERPHENAZINE AND AMITRIPTYLINE HYDROCHLORIDE (perphenazine and amitriptyline hydrochloride)

Snippet

SUPPL AP for PERPHENAZINE AND AMITRIPTYLINE HYDROCHLORIDE (PERPHENAZINE AND AMITRIPTYLINE HYDROCHLORIDE)